Illumina Inc ILMN

NAS: ILMN | ISIN: US4523271090   27/03/2026
117,67 USD (-5,41%)
(-5,41%)   27/03/2026

18 maart 2026 · Illumina and Labcorp expand collaboration to broaden access to precision oncology testing · Persbericht

16 maart 2026 · Illumina advances preventive genomics through strategic consortium with Veritas Genetics · Persbericht

5 maart 2026 · Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering · Persbericht

27 februari 2026 · Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida · Persbericht

25 februari 2026 · Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics · Persbericht

24 februari 2026 · Illumina launches TruPath Genome, setting a new standard in genomic insight · Persbericht

23 februari 2026 · Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility · Persbericht

17 februari 2026 · Illumina To Webcast Upcoming Investor Conference · Persbericht

5 februari 2026 · Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 · Persbericht

3 februari 2026 · Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally · Persbericht

30 januari 2026 · Illumina completes acquisition of SomaLogic · Persbericht

20 januari 2026 · Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology · Persbericht

13 januari 2026 · Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery · Persbericht

13 januari 2026 · Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 · Persbericht

12 januari 2026 · Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 · Persbericht

8 januari 2026 · Illumina Appoints Dr. Eric Green as Chief Medical Officer · Persbericht

6 januari 2026 · Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis · Persbericht

16 december 2025 · Illumina To Webcast Upcoming Investor Conference · Persbericht

14 december 2025 · /C O R R E C T I O N -- MyOme, Inc/ · Persbericht

11 december 2025 · Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually · Persbericht

Mijn selecties